These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 37290575)
1. Potential neonatal toxicity of new psychoactive substances. Fujiwara R; Journey M; Al-Doori F; Bell P; Judge B; Miracle K; Ito K; Jones S Pharmacol Ther; 2023 Aug; 248():108468. PubMed ID: 37290575 [TBL] [Abstract][Full Text] [Related]
2. Toxicological Analysis of Illicit Drugs Seized in Naples (Italy) and First Detection of Synthetic Cannabinoids during COVID-19 Pandemic. Carfora A; Petrella R; Ambrosio G; Fracassi I; Festinese S; Feola A; Campobasso CP Healthcare (Basel); 2022 Aug; 10(8):. PubMed ID: 36011145 [TBL] [Abstract][Full Text] [Related]
3. Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives. Radaelli D; Manfredi A; Zanon M; Fattorini P; Scopetti M; Neri M; Frisoni P; D'Errico S Curr Neuropharmacol; 2021; 19(11):2038-2048. PubMed ID: 33845747 [TBL] [Abstract][Full Text] [Related]
4. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature. Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131 [No Abstract] [Full Text] [Related]
6. New Psychoactive Substances: Which Biological Matrix Is the Best for Clinical Toxicology Screening? Wagmann L; Jacobs CM; Meyer MR Ther Drug Monit; 2022 Oct; 44(5):599-605. PubMed ID: 35175247 [TBL] [Abstract][Full Text] [Related]
7. The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines. Tyrkkö E; Andersson M; Kronstrand R Ther Drug Monit; 2016 Apr; 38(2):190-216. PubMed ID: 26587869 [TBL] [Abstract][Full Text] [Related]
8. Occurrence and Mass Loading of Synthetic Opioids, Synthetic Cathinones, and Synthetic Cannabinoids in Wastewater Treatment Plants in Four U.S. Communities. O'Rourke CE; Subedi B Environ Sci Technol; 2020 Jun; 54(11):6661-6670. PubMed ID: 32356976 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic Studies for Evaluation of NPS Toxicity: Focus on Synthetic Cannabinoids and Cathinones. Mazdai L; Fabbri M; Tirri M; Corli G; Arfè R; Marchetti B; Bilel S; Bergamin E; Gaudio RM; Rubini M; De-Giorgio F; Marti M Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740419 [TBL] [Abstract][Full Text] [Related]
10. Toxicology and management of novel psychoactive drugs. Kersten BP; McLaughlin ME J Pharm Pract; 2015 Feb; 28(1):50-65. PubMed ID: 25261428 [TBL] [Abstract][Full Text] [Related]
11. Self-reported use of novel psychoactive substances among attendees of electronic dance music venues. Palamar JJ; Acosta P; Sherman S; Ompad DC; Cleland CM Am J Drug Alcohol Abuse; 2016 Nov; 42(6):624-632. PubMed ID: 27315522 [TBL] [Abstract][Full Text] [Related]
12. An overview of recent developments in the analytical detection of new psychoactive substances (NPSs). Smith JP; Sutcliffe OB; Banks CE Analyst; 2015 Aug; 140(15):4932-48. PubMed ID: 26031385 [TBL] [Abstract][Full Text] [Related]
13. Effects of unconventional recreational drug use in pregnancy. Chomchai S; Phuditshinnapatra J; Mekavuthikul P; Chomchai C Semin Fetal Neonatal Med; 2019 Apr; 24(2):142-148. PubMed ID: 30744980 [TBL] [Abstract][Full Text] [Related]
14. Maternal Hair and Neonatal Meconium to Assess Gestational Consumption and Prenatal Exposure to Drugs of Abuse and Psychoactive Drugs. Cortes L; Almeida L; Sabra S; Muniesa M; Busardo FP; Garcia-Algar O; Gomez-Roig MD Curr Pharm Biotechnol; 2018; 19(2):136-143. PubMed ID: 29621962 [TBL] [Abstract][Full Text] [Related]
15. 25C-NBF, a new psychoactive substance, has addictive and neurotoxic potential in rodents. Hur KH; Kim SE; Lee BR; Ko YH; Seo JY; Kim SK; Ma SX; Kim YJ; Jeong Y; Pham DT; Trinh QD; Shin EJ; Kim HC; Lee YS; Lee SY; Jang CG Arch Toxicol; 2020 Jul; 94(7):2505-2516. PubMed ID: 32296860 [TBL] [Abstract][Full Text] [Related]
16. Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones. Patrick ME; O'Malley PM; Kloska DD; Schulenberg JE; Johnston LD; Miech RA; Bachman JG Drug Alcohol Rev; 2016 Sep; 35(5):586-90. PubMed ID: 26711540 [TBL] [Abstract][Full Text] [Related]
18. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting. Palamar JJ; Martins SS; Su MK; Ompad DC Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051 [TBL] [Abstract][Full Text] [Related]
19. Rapid screening and determination of 11 new psychoactive substances by direct analysis in real time mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. Nie H; Li X; Hua Z; Pan W; Bai Y; Fu X Rapid Commun Mass Spectrom; 2016 Aug; 30 Suppl 1():141-6. PubMed ID: 27539429 [TBL] [Abstract][Full Text] [Related]
20. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling. Liechti M Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]